San Diego cell therapy CDMO acquired by Great Point Partners
Performance Cell Manufacturing, a CDMO with a focus on manufacturing cell therapies, has been acquired by Great Point Partners and will now operate under the name Cellipont Bioservices.
Archives for January 13, 2022
JP Morgan Healthcare Conference 2022
Korea’s Samsung Bio reveals massive capacity boost on the cards
Samsung Biologics flags further facility construction plans, with biologics, cell and gene therapies and next-generation vaccines to be the focus of those new sites.
CMS decision to restrict Aduhelm coverage could have ‘ripple effect’ on other potential therapies
This week the US Centers for Medicare & Medicaid Services (CMS) has announced a long-awaited proposal for Aduhelm coverage: proposing it would only cover the recently approved Alzheimer’s Drug for people in qualifying clinical trials. This could have a...
Protagen, BioAnalytix, and GeneWerk unveil combined CRO business: ProtaGene
Protagen, BioAnalytix, and GeneWerk this week announced their unified operations and re-brand as ProtaGene, a CRO partner for the biologics and cell and gene therapy developers, from discovery to commercialization.